MAC glucuronide phenol-linked SN-38, a pH-sensitive lactone and DNA topoisomerase I inhibitor drug linker, exhibits cytotoxicity in L540cy and Ramos cells, with IC50 values of 113 ng/mL and 67 ng/mL, respectively[1].

GGFG-PAB-MMAE (Comp 58054-1) 作为一种高效的 ADC 药物-连接子偶联物，由 ADC linker (GGFG-PAB) 和抑制微管蛋白聚合的有效成分 MMAE 构成。

Compound 94 (MC-GGFG-PAB-Exatecan) 是一种用于合成ADC的ADC药物-连接子偶联物。

MC-GGFG-AM-(10Me-11F-Camptothecin)intermediate-1(化合物19-2)作为合成MC-GGFG-AM-(10Me-11F-Camptothecin)的关键中间体,具备添加修饰基团的能力.该MC-GGFG-AM-(10Me-11F-Camptothecin)为药物-Linker偶联物,主要用途是用于ADCs的合成.

Val-Cit-PABC-DOX (compound 10109) 作为一种ε-聚-L-赖氨酸基的药物偶联体，属于抗体药物偶联物 (ADC) 的活性连接部分 (drug-linker conjugate)。该化合物是通过 Val-Cit-PABC 链接 DNAtopoisomeraseI 与 topoisomeraseII 的抑制剂 Doxorubicin 来构成的。

GGFG-PAB-Exatecan 由有毒分子 Exatecan 和连接子 GGFG-PAB 构成，可作为合成 ADC 分子的药物-连接子偶合物使用。

TLR7/8 agonist 4 hydroxy-PEG10-acid hydrochloride (compound 9) is a drug-linker conjugate used in antibody-drug conjugates (ADCs) with high efficacy against tumors. It consists of TLR7/8 agonist 4, a potent TLR7/8 agonist, linked to the ADC linker hydroxy-PEG10-acid which can be cleaved.

Mal-Phe-C4-VC-PAB-MMAE is a chemical compound resulting from the conjugation of monomethyl auristatin E (MMAE), a potent tubulin inhibitor serving as a toxin payload in antibody-drug conjugates, with a Mal-Phe-C4-VC-PAB linker.

Sulfo-PDBA-DM4 is a drug-linker conjugate for antibody-drug conjugate (ADC) applications, combining the potent tubulin inhibitor DM4 with the gluthatione-cleavable linker Sulfo-PDBA. This configuration harnesses DM4's cytotoxic potential through Sulfo-PDBA's targeted delivery mechanism.